ArriVent BioPharma, Inc. Common Stock
← Back to AVBP Overview

ArriVent BioPharma, Inc. Common Stock (AVBP)

Earnings & Profitability History

Latest EPS

$-0.84

Net Income

-35544000

Financial Fundamentals

AVBPQuarterly Data • 5Y View

Historical Data Table

Quarterly Net Income & EPS

DateNet Income ($B)NI YoY %TTM NIEPSEPS YoY %TTM EPS
2025-12-31-0.04-72.3%-0.17-0.84-37.7%-4.47
2025-09-30-0.03-70.1%-0.15-0.83-36.1%-4.24
2025-06-30-0.03-43.5%-0.14-0.90-38.5%-4.02
2025-03-31-0.06-269.7%-0.13-1.90-265.4%-3.77
2024-12-31-0.02+2.6%-0.08-0.61+3.2%-2.39
2024-09-30-0.02-42.8%-0.08-0.61-41.9%-2.41
2024-06-30-0.02-1.4%-0.07-0.65-1.6%-2.23
2024-03-31-0.02-43.1%-0.07-0.52-44.4%-2.22
2023-12-31-0.02-103.0%-0.07-0.63-103.2%-2.06
2023-09-30-0.01-22.4%-0.06-0.43-22.9%-1.74
2023-06-30-0.02-193.5%-0.06-0.64+88.9%-1.66
2023-03-31-0.01-65.7%-0.04-0.36+93.7%-6.78
2022-12-31-0.01-0.04-0.31-12.18
2022-09-30-0.01-0.35
2022-06-30-0.01-5.76
2022-03-31-0.01-5.76

Annual Performance

YearNet Income ($B)Growth %EPSEPS Growth %
2025-0.17-106.6%-4.32-68.8%
2024-0.08-16.1%-2.56-18.0%
2023-0.07-87.9%-2.17-97.3%
2022-0.04+28.5%-1.10+97.3%
2021-0.05-40.44